Welcome to our dedicated page for Ricebran Technologies news (Ticker: RIBT), a resource for investors and traders seeking the latest updates and insights on Ricebran Technologies stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ricebran Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ricebran Technologies's position in the market.
RiceBran Technologies (NASDAQ:RIBT) has successfully regained compliance with Nasdaq's Listing Rule 5550(a)(2), which mandates a minimum bid price of $1.00 per share. This determination follows a period where the company's stock maintained the required price for 10 consecutive business days. Nasdaq had previously notified RiceBran of its non-compliance in July 2020, granting a 180-day extension to meet the requirements. The company achieved compliance ahead of the July 26, 2021 deadline due to favorable market conditions.
RiceBran Technologies (NASDAQ: RIBT) reported its Q3 2020 financial results, showing revenues of $5.2 million, a slight decline of 3% year-over-year. Notably, Golden Ridge faced a 50% revenue drop due to grain acquisition issues. However, core RiceBran revenue grew due to demand for SRB derivatives. MGI revenues surged by 45% driven by capacity expansion. Adjusted EBITDA losses narrowed to $1.8 million, driven by cost reductions, while net losses decreased to $2.8 million. With $3.9 million cash on hand, the company aims for further growth and improved profitability in 2021.
RiceBran Technologies (NASDAQ: RIBT) announced a conference call scheduled for November 5, 2020, at 4:30 p.m. EST to discuss its Q3 2020 financial results ending September 30, 2020. Executive Chairman Peter Bradley and CFO Todd Mitchell will address the results. Interested parties can join via the US dial-in numbers, or access the call via webcast at ViaVid. The Company specializes in value-added products derived from rice bran, targeting food and nutritional sectors.
RiceBran Technologies (Nasdaq: RIBT) reported Q2 2020 results, revealing a 5% decline in revenues to $5.9 million, attributed mainly to lower sales in the stabilized rice bran segment and significant production slowdown at Golden Ridge due to rough rice supply shortages.
Gross losses increased to $1.2 million, while SG&A expenses fell by 23% to $2.6 million. The net loss was $3.9 million, slightly higher than last year. Despite challenges, liquidity remains solid with over $3.3 million in cash and $2 million borrowing capacity. Strategic reviews and cost-cutting initiatives are underway.
RiceBran Technologies (NASDAQ: RIBT) announced a conference call to discuss its Q2 2020 financial results on August 12, 2020, at 4:30 p.m. EDT, hosted by CEO Brent Rystrom and CFO Todd Mitchell. The call will be accessible via direct dial-in and webcast, with replay options available. RiceBran Technologies is a leader in producing value-added products from rice bran, targeting markets such as food and animal nutrition. For further details, investors can check the company's filings or visit their website.